USA Antiemetic Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antiemetic Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antiemetic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antiemetic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lupin

    • Glenmark

    • Merck

    • Pfizer

    • GlaxoSmithKline

    • Johnson & Johnson

    • IPCA Laboratories

    • Eli Lilly

    • Takeda Pharmaceutical

    • Helsinn Healthcare

    • Eisai

    • Bristol-Myers Squibb

    • Novartis

    • RedHill

    • Abbott

    • Sanofi

    • Heron Therapeutics

    • Sun Pharmaceutical Industries

    • Cipla

    By Type:

    • Dopamine Antagonist

    • 5-HT-3 Receptor Antagonist

    • NK1 Receptor Antagonist

    • Cannabinoid Receptor Antagonist

    By End-User:

    • Chemotherapy

    • Gastroenteritis

    • Surgery

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antiemetic Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Antiemetic Drugs Market Size and Growth Rate of Dopamine Antagonist from 2016 to 2027

      • 1.3.2 USA Antiemetic Drugs Market Size and Growth Rate of 5-HT-3 Receptor Antagonist from 2016 to 2027

      • 1.3.3 USA Antiemetic Drugs Market Size and Growth Rate of NK1 Receptor Antagonist from 2016 to 2027

      • 1.3.4 USA Antiemetic Drugs Market Size and Growth Rate of Cannabinoid Receptor Antagonist from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Antiemetic Drugs Market Size and Growth Rate of Chemotherapy from 2016 to 2027

      • 1.4.2 USA Antiemetic Drugs Market Size and Growth Rate of Gastroenteritis from 2016 to 2027

      • 1.4.3 USA Antiemetic Drugs Market Size and Growth Rate of Surgery from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Antiemetic Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antiemetic Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Dopamine Antagonist

      • 3.4.2 Market Size and Growth Rate of 5-HT-3 Receptor Antagonist

      • 3.4.3 Market Size and Growth Rate of NK1 Receptor Antagonist

      • 3.4.4 Market Size and Growth Rate of Cannabinoid Receptor Antagonist

    4 Segmentation of Antiemetic Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antiemetic Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antiemetic Drugs in Chemotherapy

      • 4.4.2 Market Size and Growth Rate of Antiemetic Drugs in Gastroenteritis

      • 4.4.3 Market Size and Growth Rate of Antiemetic Drugs in Surgery

    5 Market Analysis by Regions

    • 5.1 USA Antiemetic Drugs Production Analysis by Regions

    • 5.2 USA Antiemetic Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Antiemetic Drugs Landscape Analysis

    • 6.1 West USA Antiemetic Drugs Landscape Analysis by Major Types

    • 6.2 West USA Antiemetic Drugs Landscape Analysis by Major End-Users

    7 South USA Antiemetic Drugs Landscape Analysis

    • 7.1 South USA Antiemetic Drugs Landscape Analysis by Major Types

    • 7.2 South USA Antiemetic Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Antiemetic Drugs Landscape Analysis

    • 8.1 Middle West USA Antiemetic Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Antiemetic Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Antiemetic Drugs Landscape Analysis

    • 9.1 Northeast USA Antiemetic Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Antiemetic Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Lupin

        • 10.1.1 Lupin Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Glenmark

        • 10.2.1 Glenmark Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Merck

        • 10.3.1 Merck Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Pfizer

        • 10.4.1 Pfizer Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 GlaxoSmithKline

        • 10.5.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Johnson & Johnson

        • 10.6.1 Johnson & Johnson Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 IPCA Laboratories

        • 10.7.1 IPCA Laboratories Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Eli Lilly

        • 10.8.1 Eli Lilly Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Takeda Pharmaceutical

        • 10.9.1 Takeda Pharmaceutical Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Helsinn Healthcare

        • 10.10.1 Helsinn Healthcare Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Eisai

        • 10.11.1 Eisai Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Bristol-Myers Squibb

        • 10.12.1 Bristol-Myers Squibb Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Novartis

        • 10.13.1 Novartis Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 RedHill

        • 10.14.1 RedHill Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Abbott

        • 10.15.1 Abbott Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Sanofi

        • 10.16.1 Sanofi Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Heron Therapeutics

        • 10.17.1 Heron Therapeutics Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Sun Pharmaceutical Industries

        • 10.18.1 Sun Pharmaceutical Industries Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

      • 10.19 Cipla

        • 10.19.1 Cipla Company Profile and Recent Development

        • 10.19.2 Market Performance

        • 10.19.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of Dopamine Antagonist from 2016 to 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of 5-HT-3 Receptor Antagonist from 2016 to 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of NK1 Receptor Antagonist from 2016 to 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of Cannabinoid Receptor Antagonist from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of Chemotherapy from 2016 to 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of Gastroenteritis from 2016 to 2027

    • Figure USA Antiemetic Drugs Market Size and Growth Rate of Surgery from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Antiemetic Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Antiemetic Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Antiemetic Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antiemetic Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Antiemetic Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Dopamine Antagonist

    • Figure Market Size and Growth Rate of 5-HT-3 Receptor Antagonist

    • Figure Market Size and Growth Rate of NK1 Receptor Antagonist

    • Figure Market Size and Growth Rate of Cannabinoid Receptor Antagonist

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Antiemetic Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Antiemetic Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Chemotherapy

    • Figure Market Size and Growth Rate of Gastroenteritis

    • Figure Market Size and Growth Rate of Surgery

    • Table USA Antiemetic Drugs Production by Regions

    • Table USA Antiemetic Drugs Production Share by Regions

    • Figure USA Antiemetic Drugs Production Share by Regions in 2016

    • Figure USA Antiemetic Drugs Production Share by Regions in 2021

    • Figure USA Antiemetic Drugs Production Share by Regions in 2027

    • Table USA Antiemetic Drugs Consumption by Regions

    • Table USA Antiemetic Drugs Consumption Share by Regions

    • Figure USA Antiemetic Drugs Consumption Share by Regions in 2016

    • Figure USA Antiemetic Drugs Consumption Share by Regions in 2021

    • Figure USA Antiemetic Drugs Consumption Share by Regions in 2027

    • Table West USA Antiemetic Drugs Consumption by Types from 2016 to 2027

    • Table West USA Antiemetic Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Antiemetic Drugs Consumption Share by Types in 2016

    • Figure West USA Antiemetic Drugs Consumption Share by Types in 2021

    • Figure West USA Antiemetic Drugs Consumption Share by Types in 2027

    • Table West USA Antiemetic Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Antiemetic Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Antiemetic Drugs Consumption Share by End-Users in 2016

    • Figure West USA Antiemetic Drugs Consumption Share by End-Users in 2021

    • Figure West USA Antiemetic Drugs Consumption Share by End-Users in 2027

    • Table South USA Antiemetic Drugs Consumption by Types from 2016 to 2027

    • Table South USA Antiemetic Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Antiemetic Drugs Consumption Share by Types in 2016

    • Figure South USA Antiemetic Drugs Consumption Share by Types in 2021

    • Figure South USA Antiemetic Drugs Consumption Share by Types in 2027

    • Table South USA Antiemetic Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Antiemetic Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Antiemetic Drugs Consumption Share by End-Users in 2016

    • Figure South USA Antiemetic Drugs Consumption Share by End-Users in 2021

    • Figure South USA Antiemetic Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Antiemetic Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Antiemetic Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Antiemetic Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Antiemetic Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Antiemetic Drugs Consumption Share by Types in 2027

    • Table Middle West USA Antiemetic Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Antiemetic Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Antiemetic Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Antiemetic Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Antiemetic Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Antiemetic Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Antiemetic Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Antiemetic Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Antiemetic Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Antiemetic Drugs Consumption Share by Types in 2027

    • Table Northeast USA Antiemetic Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Antiemetic Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Antiemetic Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Antiemetic Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Antiemetic Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin

    • Table Company Profile and Development Status of Glenmark

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark

    • Figure Sales and Growth Rate Analysis of Glenmark

    • Figure Revenue and Market Share Analysis of Glenmark

    • Table Product and Service Introduction of Glenmark

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of IPCA Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IPCA Laboratories

    • Figure Sales and Growth Rate Analysis of IPCA Laboratories

    • Figure Revenue and Market Share Analysis of IPCA Laboratories

    • Table Product and Service Introduction of IPCA Laboratories

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Takeda Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical

    • Table Product and Service Introduction of Takeda Pharmaceutical

    • Table Company Profile and Development Status of Helsinn Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Healthcare

    • Figure Sales and Growth Rate Analysis of Helsinn Healthcare

    • Figure Revenue and Market Share Analysis of Helsinn Healthcare

    • Table Product and Service Introduction of Helsinn Healthcare

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of RedHill

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RedHill

    • Figure Sales and Growth Rate Analysis of RedHill

    • Figure Revenue and Market Share Analysis of RedHill

    • Table Product and Service Introduction of RedHill

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Heron Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics

    • Figure Sales and Growth Rate Analysis of Heron Therapeutics

    • Figure Revenue and Market Share Analysis of Heron Therapeutics

    • Table Product and Service Introduction of Heron Therapeutics

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries

    • Table Product and Service Introduction of Sun Pharmaceutical Industries

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.